Home › Funds › CAPITAL FUND MANAGEMENT S.A. › VRTX

CAPITAL FUND MANAGEMENT S.A. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

CAPITAL FUND MANAGEMENT S.A. reported holding 71,088 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$35.3M, representing 0.47% of its reported portfolio and ranking #32 among its reported holdings. CAPITAL FUND MANAGEMENT S.A. has disclosed VRTX holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)71.09K sh
Reported value held$35.31M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CAPITAL FUND MANAGEMENT S.A.'s VRTX position evolved

CAPITAL FUND MANAGEMENT S.A. first disclosed a stake in VRTX in Q3 2023 at 17,500 shares (US$6.1M). The position peaked in Q1 2026 at 122,934 shares, worth US$54.9M. Across 5 filings, CAPITAL FUND MANAGEMENT S.A. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 71,088 shares valued at US$35.3M — a reduction of -51,846 shares quarter over quarter.. Notable position changes include a 42% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.50K $6.09M New
Q1 2024 13.50K $5.64M New
Q3 2024 11.50K $5.35M New
Q1 2026 122.93K $54.89M New
Q2 2026 71.09K $35.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has CAPITAL FUND MANAGEMENT S.A. held VRTX?

CAPITAL FUND MANAGEMENT S.A. has disclosed VRTX holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

What is CAPITAL FUND MANAGEMENT S.A.'s current position in VRTX?

As of Q2 2026, CAPITAL FUND MANAGEMENT S.A. holds 71.09K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $35.31M, representing 0.47% of its reported portfolio and ranking #32.

Has CAPITAL FUND MANAGEMENT S.A. been buying or selling VRTX?

In the latest 13F filing (Q2 2026), CAPITAL FUND MANAGEMENT S.A. reduced its position in VRTX. The position peaked in Q1 2026 at 122.93K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.